Global Aprepitant Market Growth 2025-2031
The global Aprepitant market size is predicted to grow from US$ 79.5 million in 2025 to US$ 100 million in 2031; it is expected to grow at a CAGR of 3.9% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Aprepitant is an antiemetic chemical compound that belongs to a class of drugs called substance P antagonists (SPA). It mediates its effect by blocking the neurokinin 1 (NK1) receptor.
Aprepitant is a medication used for preventing nausea and vomiting caused by chemotherapy. The global market for aprepitant is primarily driven by several factors. The increasing incidence of cancer worldwide is a major driver for the aprepitant market. Chemotherapy is one of the primary treatment modalities for cancer, and nausea and vomiting are common side effects of chemotherapy. Aprepitant has been proven effective in preventing these side effects, making it a vital medication in managing the quality of life for cancer patients. The rising awareness among healthcare professionals and patients about the importance of supportive care in cancer treatment is contributing to the market growth. Improved education and understanding about the side effects of chemotherapy and the availability of medications like aprepitant have led to increased demand. The growing adoption of combination therapies in cancer treatment is driving the demand for aprepitant. Aprepitant is often used in combination with other antiemetic medications to provide a comprehensive approach in preventing chemotherapy-induced nausea and vomiting. The development of generic versions of aprepitant is also contributing to its market growth. Generic versions offer cost savings and improved accessibility for patients, leading to increased adoption. The expansion of healthcare infrastructure, especially in emerging markets, is playing a significant role in driving the global market for aprepitant. As more healthcare facilities and cancer treatment centers are established, the demand for aprepitant is expected to rise. Ongoing research and development activities aimed at exploring new indications and formulations for aprepitant are further driving the market. For example, studies are being conducted to evaluate the efficacy of aprepitant in other conditions associated with nausea and vomiting, such as postoperative nausea and vomiting.
LP Information, Inc. (LPI) ' newest research report, the “Aprepitant Industry Forecast” looks at past sales and reviews total world Aprepitant sales in 2024, providing a comprehensive analysis by region and market sector of projected Aprepitant sales for 2025 through 2031. With Aprepitant sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aprepitant industry.
This Insight Report provides a comprehensive analysis of the global Aprepitant landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Aprepitant portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Aprepitant market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aprepitant and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aprepitant.
This report presents a comprehensive overview, market shares, and growth opportunities of Aprepitant market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Aprepitant market?
What factors are driving Aprepitant market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Aprepitant market opportunities vary by end market size?
How does Aprepitant break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Aprepitant is an antiemetic chemical compound that belongs to a class of drugs called substance P antagonists (SPA). It mediates its effect by blocking the neurokinin 1 (NK1) receptor.
Aprepitant is a medication used for preventing nausea and vomiting caused by chemotherapy. The global market for aprepitant is primarily driven by several factors. The increasing incidence of cancer worldwide is a major driver for the aprepitant market. Chemotherapy is one of the primary treatment modalities for cancer, and nausea and vomiting are common side effects of chemotherapy. Aprepitant has been proven effective in preventing these side effects, making it a vital medication in managing the quality of life for cancer patients. The rising awareness among healthcare professionals and patients about the importance of supportive care in cancer treatment is contributing to the market growth. Improved education and understanding about the side effects of chemotherapy and the availability of medications like aprepitant have led to increased demand. The growing adoption of combination therapies in cancer treatment is driving the demand for aprepitant. Aprepitant is often used in combination with other antiemetic medications to provide a comprehensive approach in preventing chemotherapy-induced nausea and vomiting. The development of generic versions of aprepitant is also contributing to its market growth. Generic versions offer cost savings and improved accessibility for patients, leading to increased adoption. The expansion of healthcare infrastructure, especially in emerging markets, is playing a significant role in driving the global market for aprepitant. As more healthcare facilities and cancer treatment centers are established, the demand for aprepitant is expected to rise. Ongoing research and development activities aimed at exploring new indications and formulations for aprepitant are further driving the market. For example, studies are being conducted to evaluate the efficacy of aprepitant in other conditions associated with nausea and vomiting, such as postoperative nausea and vomiting.
LP Information, Inc. (LPI) ' newest research report, the “Aprepitant Industry Forecast” looks at past sales and reviews total world Aprepitant sales in 2024, providing a comprehensive analysis by region and market sector of projected Aprepitant sales for 2025 through 2031. With Aprepitant sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aprepitant industry.
This Insight Report provides a comprehensive analysis of the global Aprepitant landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Aprepitant portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Aprepitant market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aprepitant and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aprepitant.
This report presents a comprehensive overview, market shares, and growth opportunities of Aprepitant market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Injection
- Oral
- Hospital
- Drug store
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck & Co.
- Heron Therapeutics
- Sandoz
- Glenmark Pharmaceuticals
- Shanghai Yingrui Biomedical Technology Co., Ltd.
- Vea Impex (I) Pvt. Ltd.
- Aark Pharmaceuticals
- Actiza Pharmaceutical
- Aetos Pharma
What is the 10-year outlook for the global Aprepitant market?
What factors are driving Aprepitant market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Aprepitant market opportunities vary by end market size?
How does Aprepitant break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Aprepitant Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Aprepitant by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Aprepitant by Country/Region, 2020, 2024 & 2031
2.2 Aprepitant Segment by Type
2.2.1 Injection
2.2.2 Oral
2.3 Aprepitant Sales by Type
2.3.1 Global Aprepitant Sales Market Share by Type (2020-2025)
2.3.2 Global Aprepitant Revenue and Market Share by Type (2020-2025)
2.3.3 Global Aprepitant Sale Price by Type (2020-2025)
2.4 Aprepitant Segment by Application
2.4.1 Hospital
2.4.2 Drug store
2.5 Aprepitant Sales by Application
2.5.1 Global Aprepitant Sale Market Share by Application (2020-2025)
2.5.2 Global Aprepitant Revenue and Market Share by Application (2020-2025)
2.5.3 Global Aprepitant Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Aprepitant Breakdown Data by Company
3.1.1 Global Aprepitant Annual Sales by Company (2020-2025)
3.1.2 Global Aprepitant Sales Market Share by Company (2020-2025)
3.2 Global Aprepitant Annual Revenue by Company (2020-2025)
3.2.1 Global Aprepitant Revenue by Company (2020-2025)
3.2.2 Global Aprepitant Revenue Market Share by Company (2020-2025)
3.3 Global Aprepitant Sale Price by Company
3.4 Key Manufacturers Aprepitant Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Aprepitant Product Location Distribution
3.4.2 Players Aprepitant Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR APREPITANT BY GEOGRAPHIC REGION
4.1 World Historic Aprepitant Market Size by Geographic Region (2020-2025)
4.1.1 Global Aprepitant Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Aprepitant Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Aprepitant Market Size by Country/Region (2020-2025)
4.2.1 Global Aprepitant Annual Sales by Country/Region (2020-2025)
4.2.2 Global Aprepitant Annual Revenue by Country/Region (2020-2025)
4.3 Americas Aprepitant Sales Growth
4.4 APAC Aprepitant Sales Growth
4.5 Europe Aprepitant Sales Growth
4.6 Middle East & Africa Aprepitant Sales Growth
5 AMERICAS
5.1 Americas Aprepitant Sales by Country
5.1.1 Americas Aprepitant Sales by Country (2020-2025)
5.1.2 Americas Aprepitant Revenue by Country (2020-2025)
5.2 Americas Aprepitant Sales by Type (2020-2025)
5.3 Americas Aprepitant Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Aprepitant Sales by Region
6.1.1 APAC Aprepitant Sales by Region (2020-2025)
6.1.2 APAC Aprepitant Revenue by Region (2020-2025)
6.2 APAC Aprepitant Sales by Type (2020-2025)
6.3 APAC Aprepitant Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Aprepitant by Country
7.1.1 Europe Aprepitant Sales by Country (2020-2025)
7.1.2 Europe Aprepitant Revenue by Country (2020-2025)
7.2 Europe Aprepitant Sales by Type (2020-2025)
7.3 Europe Aprepitant Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Aprepitant by Country
8.1.1 Middle East & Africa Aprepitant Sales by Country (2020-2025)
8.1.2 Middle East & Africa Aprepitant Revenue by Country (2020-2025)
8.2 Middle East & Africa Aprepitant Sales by Type (2020-2025)
8.3 Middle East & Africa Aprepitant Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Aprepitant
10.3 Manufacturing Process Analysis of Aprepitant
10.4 Industry Chain Structure of Aprepitant
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Aprepitant Distributors
11.3 Aprepitant Customer
12 WORLD FORECAST REVIEW FOR APREPITANT BY GEOGRAPHIC REGION
12.1 Global Aprepitant Market Size Forecast by Region
12.1.1 Global Aprepitant Forecast by Region (2026-2031)
12.1.2 Global Aprepitant Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Aprepitant Forecast by Type (2026-2031)
12.7 Global Aprepitant Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck & Co.
13.1.1 Merck & Co. Company Information
13.1.2 Merck & Co. Aprepitant Product Portfolios and Specifications
13.1.3 Merck & Co. Aprepitant Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck & Co. Main Business Overview
13.1.5 Merck & Co. Latest Developments
13.2 Heron Therapeutics
13.2.1 Heron Therapeutics Company Information
13.2.2 Heron Therapeutics Aprepitant Product Portfolios and Specifications
13.2.3 Heron Therapeutics Aprepitant Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Heron Therapeutics Main Business Overview
13.2.5 Heron Therapeutics Latest Developments
13.3 Sandoz
13.3.1 Sandoz Company Information
13.3.2 Sandoz Aprepitant Product Portfolios and Specifications
13.3.3 Sandoz Aprepitant Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sandoz Main Business Overview
13.3.5 Sandoz Latest Developments
13.4 Glenmark Pharmaceuticals
13.4.1 Glenmark Pharmaceuticals Company Information
13.4.2 Glenmark Pharmaceuticals Aprepitant Product Portfolios and Specifications
13.4.3 Glenmark Pharmaceuticals Aprepitant Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Glenmark Pharmaceuticals Main Business Overview
13.4.5 Glenmark Pharmaceuticals Latest Developments
13.5 Shanghai Yingrui Biomedical Technology Co., Ltd.
13.5.1 Shanghai Yingrui Biomedical Technology Co., Ltd. Company Information
13.5.2 Shanghai Yingrui Biomedical Technology Co., Ltd. Aprepitant Product Portfolios and Specifications
13.5.3 Shanghai Yingrui Biomedical Technology Co., Ltd. Aprepitant Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Shanghai Yingrui Biomedical Technology Co., Ltd. Main Business Overview
13.5.5 Shanghai Yingrui Biomedical Technology Co., Ltd. Latest Developments
13.6 Vea Impex (I) Pvt. Ltd.
13.6.1 Vea Impex (I) Pvt. Ltd. Company Information
13.6.2 Vea Impex (I) Pvt. Ltd. Aprepitant Product Portfolios and Specifications
13.6.3 Vea Impex (I) Pvt. Ltd. Aprepitant Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Vea Impex (I) Pvt. Ltd. Main Business Overview
13.6.5 Vea Impex (I) Pvt. Ltd. Latest Developments
13.7 Aark Pharmaceuticals
13.7.1 Aark Pharmaceuticals Company Information
13.7.2 Aark Pharmaceuticals Aprepitant Product Portfolios and Specifications
13.7.3 Aark Pharmaceuticals Aprepitant Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Aark Pharmaceuticals Main Business Overview
13.7.5 Aark Pharmaceuticals Latest Developments
13.8 Actiza Pharmaceutical
13.8.1 Actiza Pharmaceutical Company Information
13.8.2 Actiza Pharmaceutical Aprepitant Product Portfolios and Specifications
13.8.3 Actiza Pharmaceutical Aprepitant Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Actiza Pharmaceutical Main Business Overview
13.8.5 Actiza Pharmaceutical Latest Developments
13.9 Aetos Pharma
13.9.1 Aetos Pharma Company Information
13.9.2 Aetos Pharma Aprepitant Product Portfolios and Specifications
13.9.3 Aetos Pharma Aprepitant Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Aetos Pharma Main Business Overview
13.9.5 Aetos Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Aprepitant Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Aprepitant by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Aprepitant by Country/Region, 2020, 2024 & 2031
2.2 Aprepitant Segment by Type
2.2.1 Injection
2.2.2 Oral
2.3 Aprepitant Sales by Type
2.3.1 Global Aprepitant Sales Market Share by Type (2020-2025)
2.3.2 Global Aprepitant Revenue and Market Share by Type (2020-2025)
2.3.3 Global Aprepitant Sale Price by Type (2020-2025)
2.4 Aprepitant Segment by Application
2.4.1 Hospital
2.4.2 Drug store
2.5 Aprepitant Sales by Application
2.5.1 Global Aprepitant Sale Market Share by Application (2020-2025)
2.5.2 Global Aprepitant Revenue and Market Share by Application (2020-2025)
2.5.3 Global Aprepitant Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Aprepitant Breakdown Data by Company
3.1.1 Global Aprepitant Annual Sales by Company (2020-2025)
3.1.2 Global Aprepitant Sales Market Share by Company (2020-2025)
3.2 Global Aprepitant Annual Revenue by Company (2020-2025)
3.2.1 Global Aprepitant Revenue by Company (2020-2025)
3.2.2 Global Aprepitant Revenue Market Share by Company (2020-2025)
3.3 Global Aprepitant Sale Price by Company
3.4 Key Manufacturers Aprepitant Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Aprepitant Product Location Distribution
3.4.2 Players Aprepitant Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR APREPITANT BY GEOGRAPHIC REGION
4.1 World Historic Aprepitant Market Size by Geographic Region (2020-2025)
4.1.1 Global Aprepitant Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Aprepitant Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Aprepitant Market Size by Country/Region (2020-2025)
4.2.1 Global Aprepitant Annual Sales by Country/Region (2020-2025)
4.2.2 Global Aprepitant Annual Revenue by Country/Region (2020-2025)
4.3 Americas Aprepitant Sales Growth
4.4 APAC Aprepitant Sales Growth
4.5 Europe Aprepitant Sales Growth
4.6 Middle East & Africa Aprepitant Sales Growth
5 AMERICAS
5.1 Americas Aprepitant Sales by Country
5.1.1 Americas Aprepitant Sales by Country (2020-2025)
5.1.2 Americas Aprepitant Revenue by Country (2020-2025)
5.2 Americas Aprepitant Sales by Type (2020-2025)
5.3 Americas Aprepitant Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Aprepitant Sales by Region
6.1.1 APAC Aprepitant Sales by Region (2020-2025)
6.1.2 APAC Aprepitant Revenue by Region (2020-2025)
6.2 APAC Aprepitant Sales by Type (2020-2025)
6.3 APAC Aprepitant Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Aprepitant by Country
7.1.1 Europe Aprepitant Sales by Country (2020-2025)
7.1.2 Europe Aprepitant Revenue by Country (2020-2025)
7.2 Europe Aprepitant Sales by Type (2020-2025)
7.3 Europe Aprepitant Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Aprepitant by Country
8.1.1 Middle East & Africa Aprepitant Sales by Country (2020-2025)
8.1.2 Middle East & Africa Aprepitant Revenue by Country (2020-2025)
8.2 Middle East & Africa Aprepitant Sales by Type (2020-2025)
8.3 Middle East & Africa Aprepitant Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Aprepitant
10.3 Manufacturing Process Analysis of Aprepitant
10.4 Industry Chain Structure of Aprepitant
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Aprepitant Distributors
11.3 Aprepitant Customer
12 WORLD FORECAST REVIEW FOR APREPITANT BY GEOGRAPHIC REGION
12.1 Global Aprepitant Market Size Forecast by Region
12.1.1 Global Aprepitant Forecast by Region (2026-2031)
12.1.2 Global Aprepitant Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Aprepitant Forecast by Type (2026-2031)
12.7 Global Aprepitant Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck & Co.
13.1.1 Merck & Co. Company Information
13.1.2 Merck & Co. Aprepitant Product Portfolios and Specifications
13.1.3 Merck & Co. Aprepitant Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck & Co. Main Business Overview
13.1.5 Merck & Co. Latest Developments
13.2 Heron Therapeutics
13.2.1 Heron Therapeutics Company Information
13.2.2 Heron Therapeutics Aprepitant Product Portfolios and Specifications
13.2.3 Heron Therapeutics Aprepitant Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Heron Therapeutics Main Business Overview
13.2.5 Heron Therapeutics Latest Developments
13.3 Sandoz
13.3.1 Sandoz Company Information
13.3.2 Sandoz Aprepitant Product Portfolios and Specifications
13.3.3 Sandoz Aprepitant Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sandoz Main Business Overview
13.3.5 Sandoz Latest Developments
13.4 Glenmark Pharmaceuticals
13.4.1 Glenmark Pharmaceuticals Company Information
13.4.2 Glenmark Pharmaceuticals Aprepitant Product Portfolios and Specifications
13.4.3 Glenmark Pharmaceuticals Aprepitant Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Glenmark Pharmaceuticals Main Business Overview
13.4.5 Glenmark Pharmaceuticals Latest Developments
13.5 Shanghai Yingrui Biomedical Technology Co., Ltd.
13.5.1 Shanghai Yingrui Biomedical Technology Co., Ltd. Company Information
13.5.2 Shanghai Yingrui Biomedical Technology Co., Ltd. Aprepitant Product Portfolios and Specifications
13.5.3 Shanghai Yingrui Biomedical Technology Co., Ltd. Aprepitant Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Shanghai Yingrui Biomedical Technology Co., Ltd. Main Business Overview
13.5.5 Shanghai Yingrui Biomedical Technology Co., Ltd. Latest Developments
13.6 Vea Impex (I) Pvt. Ltd.
13.6.1 Vea Impex (I) Pvt. Ltd. Company Information
13.6.2 Vea Impex (I) Pvt. Ltd. Aprepitant Product Portfolios and Specifications
13.6.3 Vea Impex (I) Pvt. Ltd. Aprepitant Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Vea Impex (I) Pvt. Ltd. Main Business Overview
13.6.5 Vea Impex (I) Pvt. Ltd. Latest Developments
13.7 Aark Pharmaceuticals
13.7.1 Aark Pharmaceuticals Company Information
13.7.2 Aark Pharmaceuticals Aprepitant Product Portfolios and Specifications
13.7.3 Aark Pharmaceuticals Aprepitant Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Aark Pharmaceuticals Main Business Overview
13.7.5 Aark Pharmaceuticals Latest Developments
13.8 Actiza Pharmaceutical
13.8.1 Actiza Pharmaceutical Company Information
13.8.2 Actiza Pharmaceutical Aprepitant Product Portfolios and Specifications
13.8.3 Actiza Pharmaceutical Aprepitant Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Actiza Pharmaceutical Main Business Overview
13.8.5 Actiza Pharmaceutical Latest Developments
13.9 Aetos Pharma
13.9.1 Aetos Pharma Company Information
13.9.2 Aetos Pharma Aprepitant Product Portfolios and Specifications
13.9.3 Aetos Pharma Aprepitant Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Aetos Pharma Main Business Overview
13.9.5 Aetos Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Aprepitant Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Aprepitant Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Oral
Table 5. Global Aprepitant Sales by Type (2020-2025) & (K Units)
Table 6. Global Aprepitant Sales Market Share by Type (2020-2025)
Table 7. Global Aprepitant Revenue by Type (2020-2025) & ($ million)
Table 8. Global Aprepitant Revenue Market Share by Type (2020-2025)
Table 9. Global Aprepitant Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Aprepitant Sale by Application (2020-2025) & (K Units)
Table 11. Global Aprepitant Sale Market Share by Application (2020-2025)
Table 12. Global Aprepitant Revenue by Application (2020-2025) & ($ million)
Table 13. Global Aprepitant Revenue Market Share by Application (2020-2025)
Table 14. Global Aprepitant Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Aprepitant Sales by Company (2020-2025) & (K Units)
Table 16. Global Aprepitant Sales Market Share by Company (2020-2025)
Table 17. Global Aprepitant Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Aprepitant Revenue Market Share by Company (2020-2025)
Table 19. Global Aprepitant Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Aprepitant Producing Area Distribution and Sales Area
Table 21. Players Aprepitant Products Offered
Table 22. Aprepitant Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Aprepitant Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Aprepitant Sales Market Share Geographic Region (2020-2025)
Table 27. Global Aprepitant Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Aprepitant Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Aprepitant Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Aprepitant Sales Market Share by Country/Region (2020-2025)
Table 31. Global Aprepitant Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Aprepitant Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Aprepitant Sales by Country (2020-2025) & (K Units)
Table 34. Americas Aprepitant Sales Market Share by Country (2020-2025)
Table 35. Americas Aprepitant Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Aprepitant Sales by Type (2020-2025) & (K Units)
Table 37. Americas Aprepitant Sales by Application (2020-2025) & (K Units)
Table 38. APAC Aprepitant Sales by Region (2020-2025) & (K Units)
Table 39. APAC Aprepitant Sales Market Share by Region (2020-2025)
Table 40. APAC Aprepitant Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Aprepitant Sales by Type (2020-2025) & (K Units)
Table 42. APAC Aprepitant Sales by Application (2020-2025) & (K Units)
Table 43. Europe Aprepitant Sales by Country (2020-2025) & (K Units)
Table 44. Europe Aprepitant Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Aprepitant Sales by Type (2020-2025) & (K Units)
Table 46. Europe Aprepitant Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Aprepitant Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Aprepitant Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Aprepitant Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Aprepitant Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Aprepitant
Table 52. Key Market Challenges & Risks of Aprepitant
Table 53. Key Industry Trends of Aprepitant
Table 54. Aprepitant Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Aprepitant Distributors List
Table 57. Aprepitant Customer List
Table 58. Global Aprepitant Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Aprepitant Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Aprepitant Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Aprepitant Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Aprepitant Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Aprepitant Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Aprepitant Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Aprepitant Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Aprepitant Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Aprepitant Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Aprepitant Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Aprepitant Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Aprepitant Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Aprepitant Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Merck & Co. Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck & Co. Aprepitant Product Portfolios and Specifications
Table 74. Merck & Co. Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Merck & Co. Main Business
Table 76. Merck & Co. Latest Developments
Table 77. Heron Therapeutics Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 78. Heron Therapeutics Aprepitant Product Portfolios and Specifications
Table 79. Heron Therapeutics Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Heron Therapeutics Main Business
Table 81. Heron Therapeutics Latest Developments
Table 82. Sandoz Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 83. Sandoz Aprepitant Product Portfolios and Specifications
Table 84. Sandoz Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Sandoz Main Business
Table 86. Sandoz Latest Developments
Table 87. Glenmark Pharmaceuticals Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 88. Glenmark Pharmaceuticals Aprepitant Product Portfolios and Specifications
Table 89. Glenmark Pharmaceuticals Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Glenmark Pharmaceuticals Main Business
Table 91. Glenmark Pharmaceuticals Latest Developments
Table 92. Shanghai Yingrui Biomedical Technology Co., Ltd. Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 93. Shanghai Yingrui Biomedical Technology Co., Ltd. Aprepitant Product Portfolios and Specifications
Table 94. Shanghai Yingrui Biomedical Technology Co., Ltd. Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Shanghai Yingrui Biomedical Technology Co., Ltd. Main Business
Table 96. Shanghai Yingrui Biomedical Technology Co., Ltd. Latest Developments
Table 97. Vea Impex (I) Pvt. Ltd. Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 98. Vea Impex (I) Pvt. Ltd. Aprepitant Product Portfolios and Specifications
Table 99. Vea Impex (I) Pvt. Ltd. Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Vea Impex (I) Pvt. Ltd. Main Business
Table 101. Vea Impex (I) Pvt. Ltd. Latest Developments
Table 102. Aark Pharmaceuticals Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 103. Aark Pharmaceuticals Aprepitant Product Portfolios and Specifications
Table 104. Aark Pharmaceuticals Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Aark Pharmaceuticals Main Business
Table 106. Aark Pharmaceuticals Latest Developments
Table 107. Actiza Pharmaceutical Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 108. Actiza Pharmaceutical Aprepitant Product Portfolios and Specifications
Table 109. Actiza Pharmaceutical Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Actiza Pharmaceutical Main Business
Table 111. Actiza Pharmaceutical Latest Developments
Table 112. Aetos Pharma Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 113. Aetos Pharma Aprepitant Product Portfolios and Specifications
Table 114. Aetos Pharma Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Aetos Pharma Main Business
Table 116. Aetos Pharma Latest Developments
Table 1. Aprepitant Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Aprepitant Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Oral
Table 5. Global Aprepitant Sales by Type (2020-2025) & (K Units)
Table 6. Global Aprepitant Sales Market Share by Type (2020-2025)
Table 7. Global Aprepitant Revenue by Type (2020-2025) & ($ million)
Table 8. Global Aprepitant Revenue Market Share by Type (2020-2025)
Table 9. Global Aprepitant Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Aprepitant Sale by Application (2020-2025) & (K Units)
Table 11. Global Aprepitant Sale Market Share by Application (2020-2025)
Table 12. Global Aprepitant Revenue by Application (2020-2025) & ($ million)
Table 13. Global Aprepitant Revenue Market Share by Application (2020-2025)
Table 14. Global Aprepitant Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Aprepitant Sales by Company (2020-2025) & (K Units)
Table 16. Global Aprepitant Sales Market Share by Company (2020-2025)
Table 17. Global Aprepitant Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Aprepitant Revenue Market Share by Company (2020-2025)
Table 19. Global Aprepitant Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Aprepitant Producing Area Distribution and Sales Area
Table 21. Players Aprepitant Products Offered
Table 22. Aprepitant Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Aprepitant Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Aprepitant Sales Market Share Geographic Region (2020-2025)
Table 27. Global Aprepitant Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Aprepitant Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Aprepitant Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Aprepitant Sales Market Share by Country/Region (2020-2025)
Table 31. Global Aprepitant Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Aprepitant Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Aprepitant Sales by Country (2020-2025) & (K Units)
Table 34. Americas Aprepitant Sales Market Share by Country (2020-2025)
Table 35. Americas Aprepitant Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Aprepitant Sales by Type (2020-2025) & (K Units)
Table 37. Americas Aprepitant Sales by Application (2020-2025) & (K Units)
Table 38. APAC Aprepitant Sales by Region (2020-2025) & (K Units)
Table 39. APAC Aprepitant Sales Market Share by Region (2020-2025)
Table 40. APAC Aprepitant Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Aprepitant Sales by Type (2020-2025) & (K Units)
Table 42. APAC Aprepitant Sales by Application (2020-2025) & (K Units)
Table 43. Europe Aprepitant Sales by Country (2020-2025) & (K Units)
Table 44. Europe Aprepitant Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Aprepitant Sales by Type (2020-2025) & (K Units)
Table 46. Europe Aprepitant Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Aprepitant Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Aprepitant Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Aprepitant Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Aprepitant Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Aprepitant
Table 52. Key Market Challenges & Risks of Aprepitant
Table 53. Key Industry Trends of Aprepitant
Table 54. Aprepitant Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Aprepitant Distributors List
Table 57. Aprepitant Customer List
Table 58. Global Aprepitant Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Aprepitant Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Aprepitant Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Aprepitant Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Aprepitant Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Aprepitant Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Aprepitant Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Aprepitant Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Aprepitant Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Aprepitant Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Aprepitant Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Aprepitant Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Aprepitant Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Aprepitant Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Merck & Co. Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck & Co. Aprepitant Product Portfolios and Specifications
Table 74. Merck & Co. Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Merck & Co. Main Business
Table 76. Merck & Co. Latest Developments
Table 77. Heron Therapeutics Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 78. Heron Therapeutics Aprepitant Product Portfolios and Specifications
Table 79. Heron Therapeutics Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Heron Therapeutics Main Business
Table 81. Heron Therapeutics Latest Developments
Table 82. Sandoz Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 83. Sandoz Aprepitant Product Portfolios and Specifications
Table 84. Sandoz Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Sandoz Main Business
Table 86. Sandoz Latest Developments
Table 87. Glenmark Pharmaceuticals Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 88. Glenmark Pharmaceuticals Aprepitant Product Portfolios and Specifications
Table 89. Glenmark Pharmaceuticals Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Glenmark Pharmaceuticals Main Business
Table 91. Glenmark Pharmaceuticals Latest Developments
Table 92. Shanghai Yingrui Biomedical Technology Co., Ltd. Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 93. Shanghai Yingrui Biomedical Technology Co., Ltd. Aprepitant Product Portfolios and Specifications
Table 94. Shanghai Yingrui Biomedical Technology Co., Ltd. Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Shanghai Yingrui Biomedical Technology Co., Ltd. Main Business
Table 96. Shanghai Yingrui Biomedical Technology Co., Ltd. Latest Developments
Table 97. Vea Impex (I) Pvt. Ltd. Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 98. Vea Impex (I) Pvt. Ltd. Aprepitant Product Portfolios and Specifications
Table 99. Vea Impex (I) Pvt. Ltd. Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Vea Impex (I) Pvt. Ltd. Main Business
Table 101. Vea Impex (I) Pvt. Ltd. Latest Developments
Table 102. Aark Pharmaceuticals Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 103. Aark Pharmaceuticals Aprepitant Product Portfolios and Specifications
Table 104. Aark Pharmaceuticals Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Aark Pharmaceuticals Main Business
Table 106. Aark Pharmaceuticals Latest Developments
Table 107. Actiza Pharmaceutical Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 108. Actiza Pharmaceutical Aprepitant Product Portfolios and Specifications
Table 109. Actiza Pharmaceutical Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Actiza Pharmaceutical Main Business
Table 111. Actiza Pharmaceutical Latest Developments
Table 112. Aetos Pharma Basic Information, Aprepitant Manufacturing Base, Sales Area and Its Competitors
Table 113. Aetos Pharma Aprepitant Product Portfolios and Specifications
Table 114. Aetos Pharma Aprepitant Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Aetos Pharma Main Business
Table 116. Aetos Pharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Aprepitant
Figure 2. Aprepitant Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Aprepitant Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Aprepitant Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Aprepitant Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Aprepitant Sales Market Share by Country/Region (2024)
Figure 10. Aprepitant Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Injection
Figure 12. Product Picture of Oral
Figure 13. Global Aprepitant Sales Market Share by Type in 2025
Figure 14. Global Aprepitant Revenue Market Share by Type (2020-2025)
Figure 15. Aprepitant Consumed in Hospital
Figure 16. Global Aprepitant Market: Hospital (2020-2025) & (K Units)
Figure 17. Aprepitant Consumed in Drug store
Figure 18. Global Aprepitant Market: Drug store (2020-2025) & (K Units)
Figure 19. Global Aprepitant Sale Market Share by Application (2024)
Figure 20. Global Aprepitant Revenue Market Share by Application in 2025
Figure 21. Aprepitant Sales by Company in 2025 (K Units)
Figure 22. Global Aprepitant Sales Market Share by Company in 2025
Figure 23. Aprepitant Revenue by Company in 2025 ($ millions)
Figure 24. Global Aprepitant Revenue Market Share by Company in 2025
Figure 25. Global Aprepitant Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Aprepitant Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Aprepitant Sales 2020-2025 (K Units)
Figure 28. Americas Aprepitant Revenue 2020-2025 ($ millions)
Figure 29. APAC Aprepitant Sales 2020-2025 (K Units)
Figure 30. APAC Aprepitant Revenue 2020-2025 ($ millions)
Figure 31. Europe Aprepitant Sales 2020-2025 (K Units)
Figure 32. Europe Aprepitant Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Aprepitant Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa Aprepitant Revenue 2020-2025 ($ millions)
Figure 35. Americas Aprepitant Sales Market Share by Country in 2025
Figure 36. Americas Aprepitant Revenue Market Share by Country (2020-2025)
Figure 37. Americas Aprepitant Sales Market Share by Type (2020-2025)
Figure 38. Americas Aprepitant Sales Market Share by Application (2020-2025)
Figure 39. United States Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Aprepitant Sales Market Share by Region in 2025
Figure 44. APAC Aprepitant Revenue Market Share by Region (2020-2025)
Figure 45. APAC Aprepitant Sales Market Share by Type (2020-2025)
Figure 46. APAC Aprepitant Sales Market Share by Application (2020-2025)
Figure 47. China Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 51. India Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Aprepitant Sales Market Share by Country in 2025
Figure 55. Europe Aprepitant Revenue Market Share by Country (2020-2025)
Figure 56. Europe Aprepitant Sales Market Share by Type (2020-2025)
Figure 57. Europe Aprepitant Sales Market Share by Application (2020-2025)
Figure 58. Germany Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 59. France Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Aprepitant Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Aprepitant Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Aprepitant Sales Market Share by Application (2020-2025)
Figure 66. Egypt Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Aprepitant in 2025
Figure 72. Manufacturing Process Analysis of Aprepitant
Figure 73. Industry Chain Structure of Aprepitant
Figure 74. Channels of Distribution
Figure 75. Global Aprepitant Sales Market Forecast by Region (2026-2031)
Figure 76. Global Aprepitant Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Aprepitant Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Aprepitant Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Aprepitant Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Aprepitant Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Aprepitant
Figure 2. Aprepitant Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Aprepitant Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Aprepitant Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Aprepitant Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Aprepitant Sales Market Share by Country/Region (2024)
Figure 10. Aprepitant Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Injection
Figure 12. Product Picture of Oral
Figure 13. Global Aprepitant Sales Market Share by Type in 2025
Figure 14. Global Aprepitant Revenue Market Share by Type (2020-2025)
Figure 15. Aprepitant Consumed in Hospital
Figure 16. Global Aprepitant Market: Hospital (2020-2025) & (K Units)
Figure 17. Aprepitant Consumed in Drug store
Figure 18. Global Aprepitant Market: Drug store (2020-2025) & (K Units)
Figure 19. Global Aprepitant Sale Market Share by Application (2024)
Figure 20. Global Aprepitant Revenue Market Share by Application in 2025
Figure 21. Aprepitant Sales by Company in 2025 (K Units)
Figure 22. Global Aprepitant Sales Market Share by Company in 2025
Figure 23. Aprepitant Revenue by Company in 2025 ($ millions)
Figure 24. Global Aprepitant Revenue Market Share by Company in 2025
Figure 25. Global Aprepitant Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Aprepitant Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Aprepitant Sales 2020-2025 (K Units)
Figure 28. Americas Aprepitant Revenue 2020-2025 ($ millions)
Figure 29. APAC Aprepitant Sales 2020-2025 (K Units)
Figure 30. APAC Aprepitant Revenue 2020-2025 ($ millions)
Figure 31. Europe Aprepitant Sales 2020-2025 (K Units)
Figure 32. Europe Aprepitant Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Aprepitant Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa Aprepitant Revenue 2020-2025 ($ millions)
Figure 35. Americas Aprepitant Sales Market Share by Country in 2025
Figure 36. Americas Aprepitant Revenue Market Share by Country (2020-2025)
Figure 37. Americas Aprepitant Sales Market Share by Type (2020-2025)
Figure 38. Americas Aprepitant Sales Market Share by Application (2020-2025)
Figure 39. United States Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Aprepitant Sales Market Share by Region in 2025
Figure 44. APAC Aprepitant Revenue Market Share by Region (2020-2025)
Figure 45. APAC Aprepitant Sales Market Share by Type (2020-2025)
Figure 46. APAC Aprepitant Sales Market Share by Application (2020-2025)
Figure 47. China Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 51. India Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Aprepitant Sales Market Share by Country in 2025
Figure 55. Europe Aprepitant Revenue Market Share by Country (2020-2025)
Figure 56. Europe Aprepitant Sales Market Share by Type (2020-2025)
Figure 57. Europe Aprepitant Sales Market Share by Application (2020-2025)
Figure 58. Germany Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 59. France Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Aprepitant Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Aprepitant Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Aprepitant Sales Market Share by Application (2020-2025)
Figure 66. Egypt Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Aprepitant Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Aprepitant in 2025
Figure 72. Manufacturing Process Analysis of Aprepitant
Figure 73. Industry Chain Structure of Aprepitant
Figure 74. Channels of Distribution
Figure 75. Global Aprepitant Sales Market Forecast by Region (2026-2031)
Figure 76. Global Aprepitant Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Aprepitant Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Aprepitant Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Aprepitant Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Aprepitant Revenue Market Share Forecast by Application (2026-2031)
